Bothell, Washington-based Northwest Biotherapeutics said Thursday that the firm has appointed a new CFO. Jim Johnston, J.D., has been appointd as Chief Financial Officer of the firm. Johnston has served as General Counsel of the firm since 1998, a position he will also continue serving. Northwest Biotherapeutics is developing immunotherapty treatments.